본문 바로가기
KERD
논문KCI 등재

OECD 회원국에서 COVID-19 팬더믹 위기시대 지역약사의 확장된 역할에 대한주제범위 문헌고찰

A Scoping Review on the Expected Role of Community Pharmacists in the Era of COVID-19 Pandemic Crisis Across OECD Countries

이인향|제남경
한국임상약학회 (Korean College Of Clinical Pharmacy)|2022.12|한국임상약학회지 (Korean Journal of Clinical Pharmacy)|제32권 제4호|pp. 288-302|DOI https://doi.org/10.24304/kjcp.2022.32.4.288

0

조회

0

다운로드

1

인용

0

참고문헌

키워드

COVID-19satisfactionpandemiccommunity pharmacycommunity pharmacist service
주제분류약학

초록

Objective: Community pharmacists are frontline health care providers, but have been considered as underutilized professionals on adaily basis. The purpose of this scoping review was to identify information about the impact of the COVID-19 pandemic oncommunity pharmacy services and to evaluate new services that could be applicable. Methods: We searched MEDLINE andEMBASE for studies published up to January 10, 2020. Search terms consisted of keywords relevant to this review, including“COVID-19”, “community pharmacy”, and “community pharmacist”. This review targeted studies of pharmacist services providedby community pharmacies in OECD member countries during the COVID-19 pandemic period. Results: Twenty-seven studieswere included in this review. Changes in community pharmacist services due to the COVID-19 pandemic were broadly classifiedinto four categories. First, as the face-to-face services became challenging, various non-face-to-face services were being tried. Second, community pharmacists directly participated in the services to prevent the spread of COVID-19. Third, communitypharmacists made efforts to support continuity of care for patients who experienced difficulties due to the reduced professional careas health and medical resources are concentrated in response to COVID-19. Fourth, community pharmacist services were emerging,targeting patients suffering from greater health inequality during the pandemic. Patients expressed high demand and satisfaction forthe service of the community pharmacist, and pharmacists reported self-efficacy and professional pride. Conclusion: This studydemonstrated that in the era of the COVID-19 pandemic, various community pharmacist services have been tried and receivedpositive evaluations from patients in several OECD countries.

Abstract

Objective: Community pharmacists are frontline health care providers, but have been considered as underutilized professionals on adaily basis. The purpose of this scoping review was to identify information about the impact of the COVID-19 pandemic oncommunity pharmacy services and to evaluate new services that could be applicable. Methods: We searched MEDLINE andEMBASE for studies published up to January 10, 2020. Search terms consisted of keywords relevant to this review, including“COVID-19”, “community pharmacy”, and “community pharmacist”. This review targeted studies of pharmacist services providedby community pharmacies in OECD member countries during the COVID-19 pandemic period. Results: Twenty-seven studieswere included in this review. Changes in community pharmacist services due to the COVID-19 pandemic were broadly classifiedinto four categories. First, as the face-to-face services became challenging, various non-face-to-face services were being tried. Second, community pharmacists directly participated in the services to prevent the spread of COVID-19. Third, communitypharmacists made efforts to support continuity of care for patients who experienced difficulties due to the reduced professional careas health and medical resources are concentrated in response to COVID-19. Fourth, community pharmacist services were emerging,targeting patients suffering from greater health inequality during the pandemic. Patients expressed high demand and satisfaction forthe service of the community pharmacist, and pharmacists reported self-efficacy and professional pride. Conclusion: This studydemonstrated that in the era of the COVID-19 pandemic, various community pharmacist services have been tried and receivedpositive evaluations from patients in several OECD countries.

참고문헌 (67)

  1. "Declaration of Astana"[URL]
  3. Iacobucci G, "Covid-19 : all non-urgent elective surgery is suspended for at least three months in England", BMJ, 368, pp.m1106~ (2020)
  4. Rimmer A, "Covid-19 : GPs can stop health checks for over 75s and routine medicine reviews", BMJ, 368, pp.m1157~ (2020)
  5. Ahn S, "Associations of the COVID-19 pandemic with older individuals' healthcare utilization and self-reported health status : a longitudinal analysis from Singapore", BMC Health Serv Res, 22(1), pp.66~ (2022)
  6. Birkmeyer JD, "The impact of the COVID-19 pandemic on hospital admissions in the United States", Health Aff, 39(11), pp.2010~2017 (2020)
  7. Lantelme P, "Worrying decrease in hospital admissions for myocardial infarction during the COVID-19pandemic", Arch Cardiovasc Dis, 113(6-7), pp.443~447 (2020)
  8. "The Impact of COVID-19 on Outpatient Visits in 2020: Visits Remained Stable, Despite a Late Surge in Cases" (2021)[URL]
  9. Dopfer C, "COVID-19related reduction in pediatric emergency healthcare utilization-a concerning trend", BMC Pediatr, 20(1), pp.427~ (2020)
  10. Lam W, "The nature of conflict in community pharmacy-A pilot study of pharmacists’ experiences during the COVID-19 pandemic", Res Social Adm Pharm, 18(7), pp.3164~3173 (2022)
  11. Kone A, "The impact of traumatic experiences, coping mechanisms, and workplace benefits on the mental health of U.S. public health workers during the COVID-19pandemic", Ann Epidemiol, 74, pp.66~74 (2022)
  12. Sheehan KA, "“Don’t just study our distress, do something”: Implementing and evaluating a modified stepped-care model for health care worker mental health during the COVID-19 pandemic", Can J Psychiatry, 68(1), pp.43~53 (2023)
  13. Sayarshad HR, "Personal protective equipment market coordination using subsidy", Sustain Cities Soc, 85, pp.104044~ (2022)
  14. "<‘Corona 19’ Super Emergency> The app saying ‘Masks in stock,’ but actually “None” at pharmacy"[URL]
  15. "“What should I do? All cold medicine is out of stock” Pharmacies are at war" (2022)[URL]
  16. Cadogan CA, "On the frontline against COVID-19 : Community pharmacists' contribution during a public health crisis", Res Social Adm Pharm, 17(1), pp.2032~2035 (2021)
  17. El Hadidi S, "What we learnt after looking back at the community pharmacists’ experiences worldwide in COVID-19pandemic", J Pharm Pract, pp.8971900211036093~ (2021)
  18. "KPA, supply the same quantity and uniform price of masks to pharmacies nationwide" (2020)[URL]
  19. 오난숙, "공공심야약국 도입 필요성에 대한 인식 및 운영방안: 경상북도 사례", 한국임상약학회지, 32(2), pp.93~105 (2022), 한국임상약학회[DOI]
  20. Tricco AC, "PRISMA Extension for Scoping Reviews(PRISMA-ScR) : Checklist and explanation", Ann Intern Med, 169(7), pp.467~473 (2018)
  21. Amariles P, "How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal", Res Social Adm Pharm, 17(1), pp.1988~1989 (2021)
  22. Baratta F, "The relationship between customers and community pharmacies during the covid-19(Sarscov-2)pandemic : A survey from Italy", Int J Environ Res Public health, 18(18), pp.9582~ (2021)
  23. Bourdin A, "Response to the first wave of the COVID-19 pandemic in the community pharmacy of a University Center for Primary Care and Public Health", Res Social Adm Pharm, 18(4), pp.2706~2710 (2022)
  24. Cerbin-Koczorowska M, "Pharmacists’Preparedness to Patients Education at the Time of Pandemic-A Cross-Sectional Study with an Example of SARS-CoV-2 Outbreak in Poland", Int J Environ Res Public health, 17(18), pp.6659~ (2020)
  25. Crowley D, "A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19pandemic : a report", Harm Reduct J, 17(1), pp.49~ (2020)
  26. Daskalakis G, "Investigating community pharmacy take home naloxone dispensing during COVID-19 : The impact of one public health crisis on another", Pharmacy, 9(3), pp.129~ (2021)
  27. Giua C, "Community pharmacist’s professional adaptation amid Covid-19 emergency : a national survey on Italian pharmacists", Int J Clin Pharm, 43(3), pp.708~715 (2021)
  28. Gregory PAM, "COVID-19: How did community pharmacies get through the first wave?", Can Pharm J (Ott), 153(5), pp.243~251 (2020)
  29. Imlach F, "E-prescribing and access to prescription medicines during lockdown : experience of patients in Aotearoa", New Zealand, 2021, pp.22(1), 140~
  30. Klepser NS, "Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities", Res Social Adm Pharm, 17(9), pp.1574~1578 (2021)
  31. Koster ES, "Impact of the COVID-19epidemic on the provision of pharmaceutical care in community pharmacies", Res Social Adm Pharm, 17(1), pp.2002~2004 (2021)
  32. Lim RH, "The experiences of the community pharmacy team in supporting people with dementia and family carers with medication management during the COVID-19pandemic", Res Social Adm Pharm, 17(1), pp.1825~1831 (2021)
  33. Lin CH, "The pharmaceutical practice of mask distribution by pharmacists in Taiwan’s community pharmacies under the Mask Real-Name System, in response to the COVID-19 outbreak", Cost EffResour Alloc, 18, pp.45~ (2020)
  34. Lin YW, "Vaccination distribution by community pharmacists under the COVID-19 vaccine appointment system in Taiwan", Cost EffResour Alloc, 19(1), pp.76~ (2021)
  35. Lubi K, "A qualitative study of the challenges in rearranging community pharmacy service provision during the COVID-19 public health emergency: The prism of social practice theory", Public Health Pract(Oxf), 2, pp.100212~ (2021)
  36. Mamiya KT, "Changes in Japanese pharmacists’recognition of their role in community public health before and after the spread of COVID-19", Pharmacy(Basel), 9(3), pp.154~ (2021)
  37. Manouchehri M, "The real impact of COVID-19 on community pharmacy professionals as part of the primary health care frontier workforce in Spain", J Pharm Pharmacogn Res, 9(6), pp.878~891 (2021)
  38. Molas ME, "Impact of the COVID-19pandemic: Community and hospital shared pharmaceutical care model. Satisfaction and acceptability of patients with HIV infection on antiretroviral treatment", Rev Esp Quimioter, 35(1), pp.71~75 (2022)
  39. Okuyan B, "Community pharmacy cognitive services during the COVID-19 pandemic: A descriptive study of practices, precautions taken, perceived enablers and barriers and burnout", Int J Clin Pract, 75(12), pp.e14834~ (2021)
  40. Patel J, "Pharmacist-provided SARSCoV-2 testing targeting a majority-Hispanic community during the early COVID-19 pandemic : Results of a patient perception survey", J Am Pharm Assoc, 62(1), pp.187~193 (2022)
  41. Peláez Bejarano A, "Implementation of a novel home delivery service during pandemic", Eur J Hosp Pharm, 28(2), pp.e120~e123 (2021)
  42. Stämpfli D, "Community pharmacist-administered covid-19vaccinations: A pilot customer survey on satisfaction and motivation to get vaccinated", Vaccines(Basel), 9(11), pp.1320~ (2021)
  43. Stoa MK, "Adaptations made to delivery of comprehensive medication management in the community pharmacy setting during COVID-19", Explor Res Clin Soc Pharm, 4, pp.100089~ (2021)
  44. Toth JM, "Caregivers’Perspectives of Pharmacist Intervention in Children’s Antibiotic Prescriptions for Upper Respiratory Tract Infections", J Pharm Pract, pp.8971900211033459~ (2021)
  45. Zaidi STR, "Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19pandemic : Results from a national survey", Res Social Adm Pharm, 17(1), pp.1832~1837 (2021)
  46. Zimmermann A, "Assessment of pharmacists prescribing practices in Poland-A descriptive study", Healthcare(Basel), 9(11), pp.1505~ (2021)
  47. Zozaya N, "Continuity of care between hospital pharmacies and community pharmacies, and costs avoided: A pilot experience in times of COVID-19 in Spain", Glob Reg Health Technol Assess, 8(1), pp.8~13 (2021)
  48. Jordan D, "How COVID-19 has impacted the role of pharmacists around the world", Farm Hosp, 45(2), pp.89~95 (2021)
  49. Rezahi S, "Telehealth in community pharmacy: A new “place” for the appointment-based model given COVID-19 and the future of health care", Can Pharm J (Ott), 154(6), pp.363~367 (2021)
  50. Littauer SL, "Pharmacists providing care in the outpatient setting through telemedicine models: a narrative review", Pharm Pract(Granada), 15(4), pp.1134~ (2017)
  51. Niznik JD, "Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting : A systematic review", Res Social Adm Pharm, 14(8), pp.707~717 (2018)
  52. Henderson C, "Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial", BMJ, 346, pp.f1035~ (2013)
  53. "Investigation review of Ministry of Health and Welfare, 'special pharmacy for drug delivery'" (2022)[URL]
  54. "“Discussion of institutionalization for non face-to-face service, issues of electronic prescription and drug delivery”" (2022)[URL]
  55. Smith AC, "Telehealth for global emergencies : Implications for coronavirus disease 2019(COVID-19)", J Telemed Telecare, 26(5), pp.309~313 (2020)
  56. Maidment I, "Rapid realist review of the role of community pharmacy in the public health response to COVID-19", BMJ open, 11(6), pp.e050043~ (2021)
  57. Hess K, "Community pharmacists roles during the COVID-19 pandemic", J Pharm Pract, 35(3), pp.469~476 (2022)
  58. Bambra C, "The COVID-19pandemic and health inequalities", J Epidemiol Community Health, 74(11), pp.964~968 (2020)
  59. Cohen MA, "Who are the most at-risk older adults in the COVID-19 era? It’s not just those in nursing homes", J Aging Soc Policy, 32(4-5), pp.380~386 (2020)
  60. Béland D, "COVID-19 and long-term care policy for older people in Canada", J Aging Soc Policy, 32(4-5), pp.358~364 (2020)
  61. Shinan-Altman S, "Healthcare utilization among breast cancer patients during the COVID-19 outbreak", Palliat Support Care, 18(4), pp.385~391 (2020)
  62. Kirby A, "Counting the social, psychological, and economic costs of COVID-19 for cancer patients", Support Care Cancer, 30(11), pp.8705~8731 (2022)
  63. Latif A, "Managing medicines at the end of life : a position paper for health policy and practice", J Health Organ Manag, 35(9), pp.368~377 (2021)
  64. "Seoul Pharmaceutical Association opens a forum for infectious diseases and the role of pharmacists and pharmacies" (2022)[URL]
  65. Park K, "Healthcare utilisation for elderly people at the onset of the COVID-19 pandemic in South Korea", BMC Geriatr, 22(1), pp.395~ (2022)
  66. Wasilewski MB, "Infection prevention and control across the continuum of COVID-19 care: A qualitative study of patients’, caregivers’ and providers’ experiences", Health Expect, 25(5), pp.2431~2439 (2022)
  67. Austin Z, "Resilience in the time of pandemic : The experience of community pharmacists during COVID-19", Res Social Adm Pharm, 17(1), pp.1867~1875 (2021)

관련 논문AI추천

문헌자료 고찰을 통한 우리나라 약국서비스 시행 현황김효정, 박혜경, 손현순, 오정미, 지은희, 한나영한국임상약학회 · 한국임상약학회지2015 · 제25권 제1호Implementation of Pharmaceutical Care Services During the COVID-19 Pandemic Worldwide박혜원, 안숙희, 오상현, 이소연, 정지은, 천승연한국임상약학회 · 한국임상약학회지2024 · 제34권 제4호현재와 미래 약국서비스에 대한 약사의 인식강민구, 방준석한국임상약학회 · 한국임상약학회지2017 · 제27권 제4호지역약국 약료서비스 제공의 장애요인: 약사 대상 설문조사김성옥, 박혜경, 손현순, 안형태, 주경미, 최상은, 한은아한국임상약학회 · 한국임상약학회지2015 · 제25권 제2호주요 외국 지역약국 서비스 유형별 지불보상방식정채림, 최상은한국보건경제정책학회 · 보건경제와 정책연구2013 · 제19권 제4호한국의 지역약국에서 국제통용 우수약무기준의 약료서비스 제공을 어렵게 하는 주요 장애요인의 분석: 설문조사 연구박세정, 신현택한국임상약학회 · 한국임상약학회지2014 · 제24권 제4호

이 간행물의 다른 논문 (7건)

약사의 전문직업성개발과 약학대학의 역할윤정현, 박혜민pp. 281-287지역약국 필수 실무실습 교육의 중요도, 수행도 및 교육요구도 분석 연구심미경, 임지미pp. 303-312Current Prescription Status of Contraindicated Drug Combinations Causing Serotonin Syndrome: Analysis of HIRA-NPS Data박수신, 김소영, 제남경, 류재곤pp. 313-320장기요양시설 거주 노인을 대상으로 한국형 요양원 입소 노인 약물검토 도구의타당성 검증을 위한 전향적 선행연구채현우, 전광희, 이주연, 정종현pp. 321-327The Effectiveness of Team-based Case-based Learning Approach on the Learning Outcome: A Single Course Level in a University Setting신혜연pp. 328-335
원문 보기